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ABSTRACT
Objectives: The aim of this study was to assess the interaction of a bioactive glass scaffold with cells derived from dental 
pulp, dental follicle and periodontal ligament.
Material and Methods: Impacted third molars were surgically removed from three young donors. Cells from the dental 
pulp, follicle and periodontal ligament tissues were isolated and expanded. Different cell populations were characterised 
using specific CD markers. Expanded pulp, follicle and periodontal cells were then seeded onto bioactive glass scaffolds and 
cultured in osteogenic medium or basic medium. Cell attachment, viability, proliferation and alkaline phosphatase activity 
were assessed.
Results: This study revealed good biocompatibility of the specific bioactive glass configuration tested and the osteogenic 
induction of cells derived from dental pulp, dental follicle and periodontal ligament. Osteogenic medium seemed to increase 
the differentiation pattern and dental pulp stem cells showed the most positive results compared to periodontal ligament and 
dental follicle stem cells.
Conclusions: Dental pulp stem cells combined with a bioactive glass scaffold and exposed to osteogenic medium in vitro 
represent a promising combination for future study of hard tissue regeneration in the cranio-maxillofacial skeleton.
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INTRODUCTION
Autogenous bone is still considered to be the 
gold standard for reconstructive surgery of the 
maxillofacial skeletal defects [1]. Harvesting bone, 
however, is accompanied by donor site morbidity 
and requires prolonged operative time [2]. The 
elimination of the autogenous bone graft donor site 
would be a major step forward in morbidity reduction. 
An alternative to treating bony defects is the tissue 
engineering approach. 
Tissue engineering was first described by Langer and 
Vacanti [3] as an interdisciplinary field of research 
that applies both the principles of engineering and the 
processes and phenomena of the life sciences toward 
the development of biological substitutes that restore, 
maintain, or improve tissue function.
One possibility is to improve function using the 
reserve of stem cells within the body of an individual 
in order to regenerate missing or damaged structures. 
Stem cells have the unique ability to renew 
themselves through mitotic cell division and when it 
is needed, to differentiate into one or more types of 
specialized cells. Mesenchymal stem cells (MSCs) 
were first identified from bone marrow aspirates in 
rodents [4] and subsequently a similar clonogenic 
population was identified from human bone marrow 
[5]. Bone marrow stem cells (BMSCs) were 
transplanted with an osteoconductive scaffold into 
ectopic sites of immunocompromised mice in order to 
prove their ability to form bone [6,7]. Adipose derived 
stem cells (ASCs) have been used clinically in a case 
series to reconstruct major bony defects of the cranio-
maxillofacial skeleton [8].
MSCs have been identified in different dental tissues 
such as dental pulp [9], periodontal ligament [10], 
dental follicle [11], the pulp of deciduous exfoliated 
teeth [12], and dental apical papilla [13,14]. 
Dental stem cells (DSCs) have been differentiated 
into different mesenchymal cell lineages such as 
adipocytes, chondroblasts and osteoblasts under 
defined inductive conditions in vitro [15-18]. 
DSCs have been harvested from the various tissues 
of extracted third molars, which until now, have been 
discarded after surgery [18]. This source of adult 
stem cells has the advantage of being autologous, 
without the ethical or immunologic issues related 
to embryonic stem cells. DSCs harvesting during 
otherwise necessary third molar extraction does 
not result in any additional morbidity to the patient 
compared to harvesting BMSCs or ASCs which 
require an additional surgical site.
However, while stem cells are one key factor they 
are not the only players in the tissue engineering 
paradigm. Resorbable scaffolds and bioactive 
molecules can also interact with each other as well as 
with stem cells [19].
A wide range of biomaterials have been used in the 
past as scaffolds in bone tissue engineering [20] 
including bioactive glasses [21]. These synthetic, 
silica based group of bone substitute materials have 
been proven to be bioactive and to bond directly to 
bone at its surface [22]. The release of soluble ions 
resulting from the dissolution of bioactive glasses can 
increase osteoblast proliferation and therefore enhance 
bone formation [23]. The ability of bioactive glass 
scaffold to promote bone bonding and bone formation 
through both surface-mediated and solution-mediated 
mechanisms have made it a promising bone tissue 
engineering scaffold that supports both proliferation 
and osteogenic differentiation of adipose derived stem 
cells [24,25].
Cytokines and growth factors such as bone 
morphogenetic proteins (BMPs) have been used as 
osteoinductive molecules to promote osteogenic 
differentiation and have shown promising results 
in vivo [26]. The high costs of growth factors and 
concerns with their use in supra-physiologic doses 
have encouraged the development of osteogenic 
medium (OM) as an alternative for MSCs 
differentiation in bone engineering [27].
The combination of DSCs with bioactive glass 
has not been studied together and is an important 
step in understanding the biocompatibility of this 
biomaterial with DSCs. This study aimed to assess the 
combination of a bioactive glass scaffold with stem 
cells harvested from dental pulp, dental follicle and 
periodontal ligament stem cells.
MATERIAL AND METHODS
Tooth extraction, cells isolation and culture
Impacted third molars were extracted at the Finnish 
Student Health Service of Tampere University from 
three healthy volunteer donors aged from 19, 21 and 
25 years. The collection of stem cells from tooth 
samples and their ex vivo treatment was approved 
by the Ethics Committee of the Pirkanmaa Hospital 
District, Tampere, Finland (R06009). 
One or more teeth were surgically removed from 
each of the three patients and placed into separate 
15 ml Falcon tubes for immediate transport from 
the operating room to the cell culturing laboratory 
where the individual tissues were harvested under 
laminar flow hoods. Follicular tissue was harvested 
first by removing the sac-like follicle to the cemento-
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enamel junction (CEJ). Periodontal ligament tissue 
was harvested with a scalpel by scraping the tooth 
roots apical to the CEJ, but coronal to any apical 
papilla tissue. Dental pulp tissue was collected after 
sectioning the crown of the freshly extracted molar 
away from its roots using a drill with sterile irrigation. 
The pulp tissue was harvested from the opened pulp 
chamber using a scalpel and a curette. The collected 
tissue was cut into small pieces using a sterile number 
15 scalpel and put into a Falcon tube each labelled by 
patient and the specific tissue of origin being follicle, 
pulp, or periodontal ligament. Each of the three 
tissues were cultured separately.
The following procedures reported by Lindroos et al. 
[15] were used to isolate the dental stem cells. Dental 
pulp, follicle and periodontal ligament tissues were 
transferred in separate 15 ml Falcon tubes with a 
solution consisting of Dolbecco’s phosphate-buffered 
saline (DPBS) (Lonza, BioWhittaker, Walkersville, 
MD, USA) and 1% Antibiotic-Antimycotic (a/a; 
100 U/ml penicillin, 0.1 mg/ml streptomycin, and 
0.25 mg/ml amphotericin B; Invitrogen Gibco/Life 
Technologies, Carlsbad, CA, USA).
Briefly, the pieces of dental tissues were digested with 
2 ml of Dispase 4 mg/ml and Collagenase type I 3 mg/
ml (Gibco/Life Technologies) solution in a water bath 
at 37 °C for one hour. After centrifugation and removal 
of the supernatant the resultant pellet was suspended in 
3 ml of growth medium and then the cells plated in a 6 
well plate with a 100 mm cell strainer.
The different populations of human dental stem 
cells (hDSCs) from each donor’s sample consisted 
of separately cultured periodontal ligament stem 
cells (hPDLSCs ), dental pulp (hDPSCs ) and dental 
follicle (hDFSCs). These cells were expanded in 
separate T75 cm2 polystyrene flasks (Nunc, Roskilde, 
Denmark) in maintenance medium.
The control or Basic Medium (BM) consisted of 
DMEM/F12 (Gibco), 10% Foetal Bovine Serum 
(FBS) (Gibco), 1% L-glutamine (GlutaMAX 
100X-Gibco), 1% Antibiotic-Antimycotic (a/a; 100 U/
ml penicillin, 0.1 mg/ml streptomycin, and 0.25 mg/
ml amphotericin B; Invitrogen Gibco).
The attachment of hDSCs were evaluated 
microscopically (Nikon eclipse TS100) beginning 
one day following isolation. When confluency was 
reached the cells were detached and divided into T75 
cm2 flasks. Medium change occurred every two or 
three days and the cell passages between 2 and 5 were 
used in these experiments. After expansion, hDSCs 
were cryo-preserved in gas phase nitrogen freezing 
solution consisting of 10% dimethyl sulphoxide 
(Hybri-Max; Sigma-Aldrich, St. Louis, MO, USA) in 
foetal bovine serum.
Cell characterization
The expression of surface markers of hDSCs were 
characterised using a flow cytometry (FACSAria; 
BD Biosciences, Erembodegem, Belgium). The 
following monoclonal antibodies were used: 
CD19-phycoerythrin-Cyanine (PECy7), CD45RO-
allophycocyanin (APC), CD54-fluorescein 
isothiocyanate (FITC), CD73-phycoerythrin (PE), CD 
90-APC, (BD Biosciences), FGFR-2-APC, FGFR3-
PE, ALP-APC, BMPR-IA-fluorescein isothiocyanate 
(FITC), TGF-β1 (LAP)-PE, VEGF R1-PE, VEGF 
R2-Peridinin-chlorophyll (PerCP), VEGF R3-APC, 
CD11a-APC, CD54-FITC, CD80-PE, CD86-PE, CD 
105-PE (R&D Systems, Minneapolis, MN, USA), 
and CD34-APC, HLADR-PE (Immunotools GmbH, 
Friesoythe, Germany). Three intracellular markers 
were also characterised from the same cells: VEGF-
PE, Latent TGF-β-PE, Twist-1-FITC (R&D Systems, 
Minneapolis, MN, USA) Analysis was performed on 
100,000 cells per sample and the positive expression 
was defined as the level of fluorescence greater than 
99% of the corresponding unstained cell sample.
Biomaterial preparation
BioRestoreTM (Inion, Tampere, Finland) is a 
commercially available biomaterial, already in use as 
a bioactive glass scaffold for bone grafts in clinical 
dentistry. BioRestore has a nominal composition 
of 11.1 - 12 wt% Na2O, 15 - 17.1 wt% K2O, 2.8 - 
3.3 wt% MgO, 12.7 - 15.2 wt% CaO, 2.7 - 3.8 wt% 
P2O5, 1 - 1.4 wt% B2O3, 0 - 0.6 wt% TiO2 and 48.5 
- 52 wt% SiO2. The scaffold porosity was 70% and 
scaffold proportions of 7x 7 x 3 mm were used as 
three-dimensional carriers of osteoinductive material 
for the seeding of hDSCs in this study. The scaffolds 
were first sterilised with 70% ethanol for one hour 
and washed with DPBS (Lonza, Valais, Switzerland) 
several times to avoid any ethanol entrapment inside 
the scaffold and to remove fibres detached from 
the scaffolds. The scaffolds were plated in a 24 well 
plates with 1 ml of BM which was enough to cover 
the scaffold, and incubated for 48 hours at 37 °C in 
5% CO2.
Cell seeding
Cells were seeded onto scaffolds at a density of 9.7 
x 104 cells per scaffold with 50μl of maintenance 
medium. The cells were allowed to attach for 
3 hours at 37 °C and 5% CO2. After 3 hours 1 
ml of BM was added to half of the scaffolds 
and 1 ml of osteogenic medium (OM) was added to 
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the remaining scaffolds for differentiation study. 
In addition to the constituents of BM, the OM 
contained β-glycerophoshate, dexamethasone and 
L-ascorbic acid. The OM specifically consisted of: 
DMEM/F12, 10% Foetal Bovine Serum (FBS-Gibco), 
1% L-glutamine (GlutaMAX 100X-Gibco), 1% 
Antibiotic-Antimycotic (Gibco/Life Technologies, 
Carlsbad, CA, USA), 100 nM dexamethasone 
(Sigma-Aldrich, St. Louis, MO, USA), 50 μM 
L-ascorbic acid 2-phosphate (Sigma-Aldrich, MO, 
USA), 10 mM β-glycerophoshate (Sigma-Aldrich, 
MO, USA). The medium was changed three times a 
week.
Cell attachment and viability
The evaluation of hDSCs attachment and viability 
on the bioactive glass scaffolds was performed 
qualitatively using Live/dead-staining probes 
(Molecular Probes/Invitrogen, Eugene, OR, USA) at 
day 7 and 14.
A mixture of 0.5 μM calcein acetoxymethyl 
ester (Molecular Probes) and 0.25 μM ethidium 
homodimer-1 (Molecular Probes) were used to 
stain viable and necrotic cells. The combination of 
hDSCs and bioactive glass scaffolds were covered 
and incubated with the above mentioned solution 
for 45 minutes in a dark room. The viable cells 
with green fluorescence and the dead cells with red 
fluorescence could be visualized using an Olympus 
IX51 phase contrast microscope with fluorescence 
optics (Olympus, Tokyo, Japan). Multiple images 
were captured with an Olympus DP30BW camera 
(Olympus, Tokyo, Japan).
Cell proliferation
Cell proliferation was evaluated with a Cy QUANT 
Cell Proliferation Assay Kit (CyQUANT; Molecular 
Probes) at the 7, 14 and 21 day time points.
This method evaluated DNA amount measuring the 
fluorescence which CyQuant GR dye expressed when 
bound to cellular nucleic acids. The cells were first 
lysated using 0.1% Triton-X 100 (Sigma-Aldrich, 
St. Louis, MO, USA) and then frozen immediately 
at -81 °C to facilitate cell membrane breakage. After 
one night incubation at -81 °C the cells were thawed 
and then each sample was collected in 1 ml eppendorf 
tubes. The tubes were spun to allow possible 
biomaterial residuals to precipitate before three 
parallel samples of 20 ml from each tube were added 
to a new 96-well plate (Nunc, Roskilde, Denmark). 
A solution with CyQuant GR dye, Cell-lysis buffer 
and deionized H2O was prepared according to 
the manufacturer’s instructions and added to the 96-
well plate samples. The plate was covered from light 
before measuring the fluorescence at 480/520 nm with 
a microplate reader (Victor 1420 Multilabel Counter; 
Wallac, Turku, Finland).
Alkaline phosphatase activity
Alkaline phosphatase (ALP) activity was evaluated 
quantitatively at 7, 14 and 21 days. The cell-seeded 
scaffolds were freeze-thawed twice before the ALP 
activity was evaluated. From each sample of 500 ul 
cell lysate three parallel samples of 20 ul were used 
for this test.
The working solution consisted of Stock substrate 
solution (P-nitrophenol phosphate-Sigma-Aldrich) 
and alkaline buffer solution (2-amino-2-methyl-1-
propanol-Sigma-Aldrich) and 90 ul of this solution 
was added to each parallel sample and then incubated 
at 37 °C for 15 min. A total of 50 μL of NaOH 
(1 M, Sigma-Aldrich) were added immediately after 
incubation to stop the reaction.
The yellow coloured P-nitrophenol amount, which 
was the result of ALP cleavage of phosphate groups 
from P-nitrophenol-phosphate, was measured at 405 
nm using a Victor 1420 microplate reader (Victor 
Scientific, Ambala, India).
Statistical analysis
Statistical analyses were performed using linear 
mixed-effect models using proliferation (fluorescein) 
and ALP activity (absorbance) data, and also 
separately for ALP activity normalized to DNA 
amount. Models were constructed using the function 
“lmer” in the R Software Environment for Statistical 
Computing and Graphics, version 2.13.0 (The R 
Foundation for Statistical Computing, Vienna, 
Austria). The logarithmic absorbance variable was 
used in absorbance models due to an otherwise 
skewed distribution. Separate models were estimated 
for BM and OM, separately for 7, 14 and 21 days, 
when the cell types (hPDLSCs, hPSCs, hDFSCs) 
were compared. Likewise separate models for the 
different cell types and different time points were 
estimated when BM and OM were compared. Finally 
models including medium, cell types, linear time (7, 
14 and 21 days) and also squared time-variable- were 
estimated for examining overall changes between 
time points. The cell type hPSCs or BM was used 
as a reference group. Random intercept for three 
repeated measurements of each sample were used 
together with independent random errors in all 
models.
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RESULTS
Characterization of hDSCs
Cell surface and intracellular marker expression of 
hDSCs was analysed by flow cytometry to compare 
the expression profile of cells extracted from different 
compartments including dental pulp, follicle and PDL 
(Figure 1). In general, the different hDSCs showed 
similar marker expression characteristics with some 
minor differences observed between hDSC types. The 
hDSCs showed strong expression (> 90%) for the 
markers CD73 (Ecto 5’ nucleotidase), CD90 (Thy-1) 
and CD105 (Endoglin). In contrast, hDSCs lacked (< 
2%) or had low expression (≤ 10%) of CD11a (Integrin 
alpha-L), CD19 (B4), CD34 (the hematopoietic 
progenitor and endothelial cell marker), CD45 
(leukocyte common antigen), CD80 (B7-1), CD86 
(B7-2) and HLA-DR (Major histocompatibility class 
II receptor). The largest variation between different 
hDSCs was seen in the expression of CD54, which 
showed lower expression in hDFSCs and hDPSCs. 
Twist-1 was strongly expressed in hDSCs (77 - 
99%). The expression of ALP varied between donors 
and hDSCs type, being strongest in hDFSCs. The 
expression of growth factor receptors FGFR2 and -3, 
BMPR-1A and VEGFR1, -2 and -3 was generally low 
with few exceptions. The expression of VEFGR1 was 
above 20% in hPDLSCs. The expression of growth 
factor TGF-β1 was low to moderate, varying from 1 to 
17% of the cells. In contrast, the expression of VEGF 
was strong in hDSCs. Its expression, however, varied 
dramatically between hDPSC donors (15 - 93%).
Cell attachment and viability
Live-dead staining images of the bioglass scaffolds 
seeded with hDSCs revealed good biocompatibility, 
allowing attachment and survival of all of the types 
of dental stem cells tested. The cells spread on the 
biomaterial’s fibres and changed their morphology 
to a more flattened shape compared to spindle shape 
in the plastic-cell culture wells. Furthermore hDSCs 
viability was also high and the number of red spots 
which represented dead cells was low or even absent 
at all of the time points (Figure 2).
Cell attachment and survival
The cells seeded onto one side of the bioactive 
glass scaffolds seemed to proliferate both inside and 
at the edges of the scaffold, completely reaching 
every part of the squared scaffolds. At 14 days 
some cell aggregates were clearly visible with a 
thin cell layer evident on the same side where the 
cells had been seeded. At 21 days this cell layer 
seemed to propagate to the lateral sides of the 
scaffold and eventually onto the opposite side. 
While cells were scattered throughout the scaffold 
the largest cell sheets were visible on the scaffold 
surfaces.
Linear mixed-effect analysis demonstrated a quadratic 
effect with time in proliferation rate. hDPSCs with 
BM showed a steady increase in cell numbers. 
hDPSCs with OM as well as hPDLSCs and hDFSCs 
with BM and OM all show an increase in cell numbers 
from day 7 to day 14 and a decrease from day 14 to 
day 21 (Figure 3A). There were sporadic bursts in 
proliferation at 21 days, depending on the cell donor. 
OM had a strong effect on proliferation only for 
hDPSCs, where OM showed lower values compared 
to BM. Dental follicle cells revealed the highest 
values of fluorescein independent of the medium used 
compared to the other cell types.
Figure 1. Characterization data of hDSCs by flow cytometry (hPDLSCs (PDL), hDPSCs (Pulp), hDFSCs (Follicle) where A and B list the 
CD markers and receptors tested.
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Osteogenic differentiation and ALP activity
ALP activity was evaluated quantitatively (Figure 
3B). The results showed the superiority of OM in 
inducing osteogenic differentiation of the dental stem 
cells independently of the stem cell population used. 
The ALP activity increased from day 7 to day 21 for 
each cell type and medium used.
When tested with BM the hDPSCs showed highest 
normalized ALP values at all three time points. The 
ALP values with OM show a difference with hDPSCs 
compared to hPDLSCs and hDFSCs at 21 days. At 
day 7 and day 14 the DPSCs showed higher ALP 
values.
DISCUSSION
This study attempted to profile the expression of 
surface markers of three different populations of 
DSCs. One interesting finding was the notably high 
expression of Twist-1 and VEGF by all three types of 
DSCs.
This in vitro study followed an approach similar to 
that described by Tirkkonen et al. [27] with adipose 
derived stem cells. The current study, however, used 
a variety of human DSCs and tested them with a 
commercially available bioactive glass scaffold. The 
advantages of this approach included the existence of 
Figure 2. Attachment and viability of hPDLSCs (PDL), hDPSCs (pulp) and hDFSCs (Follicle) when cultured on bioactive glass scaffolds 
for 7 and 14 days. The live/dead-staining stains viable cells green and dead cells as red.
Figure 3. Relative DNA amount (A) and quantitative ALP activity normalized to DNA amount (B) of hPDLSCs (PDL), hDPSCs (Pulp) and 
hDFSCs (Follicle) when cultured on bioactive glass scaffolds in basic (BM) or osteogenic (OM) medium for 7, 14 and 21 days.
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an already optimized in vitro protocol for isolating 
and expanding cells as well as culturing on the 
bioactive glass biomaterial using a similar protocol 
which had already been tested in vivo [27]. 
One major limitation of the study is related to the 
very limited number of participants, specifically three 
individuals. While this is a small number to draw 
conclusions from, still it is a beginning. The use of the 
term “biocompatibility” deserves discussion. With the 
complexity of immune responses and repair functions 
in the body, it may not be adequate to describe the 
biocompatibility of a biomaterial in relation to a 
single cell types, as a battery of in vitro tests do not 
determine the biocompatibility of a material, rather 
they just constitute an important step towards the 
casdcade of in vivo animal testing and future clinical 
trials.
Another disadvantage in the current study was the 
use of foetal bovine serum (FBS) instead of human 
serum as this could pose difficulty in translating these 
results to future applications. However, the source of 
serum does not seem to be so important as the results 
showed that hDSCs had comparable proliferation and 
differentiation values whether cultured in 20% Human 
serum or 10% FBS [17]. This justifies the opportunity 
to use this much less expensive medium in this 
preliminary in vitro step [17]. The results of this study 
show the potential role that the osteogenic medium 
may play in the differentiation of different populations 
of stem cells in vitro. This underscores the need to 
search for ideal combinations of bioactive molecules 
[16-18] and scaffolds [25,27] that facilitate the 
differentiation of stem cells and that could eventually 
be used safely in a future clinical environment.
This study showed that the OM was able to induce 
more profound differentiation than the BM. 
Nonetheless, the current results were obtained in vitro 
and may not be representative of the in vivo setting. 
In a previous in vitro study Tirkkonen et al. [27] 
showed the superiority of the OM compared to other 
growth factors such as VEGF, BMP7 and BMP2 
in the differentiation of adipose derived stem cells. 
The differentiation process follows a very complex 
and still unknown mechanism where cell behaviour, 
biomaterial properties and osteoinductive molecules 
play an interconnected role. 
The current results confirm the biocompatability of 
a bioactive glass scaffold, BiorestoreTM, allowing 
the proliferation of the cells seeded onto its surface. 
While this bioactive glass configuration supported 
osteogenic differentiation of the different dental stem 
cells seeded on to it, Tirkkonnen et al. [27] have 
already shown with ASCs that the use of the OM 
greatly improves this capacity.
These results are also in agreement with the 
observation that bioactive glass scaffolds increase 
osteogenic differentiation through both the release of 
soluble factors and by surface-contact mechanism. 
The structure of this scaffold allowed the proliferating 
cells to be mostly spreading on the top and at the 
edge of the squared block and this fact could be 
one of the reasons why the differentiation was 
also more evident in these areas. The explanation 
of this phenomenon could be also the fact that the 
nutrients and molecules contained in the medium 
could reach the external areas better than the 
middle and inner areas of this scaffold which are 
in a more static and isolated environment. A recent 
study showed that a dynamic environment could 
be advantageous for the differentiation of a three-
dimensional scaffold that exceeds 1 mm in vitro 
[28], but the same phenomena could be present in 
vivo. 
The analysis of the difference between the three 
different populations of dental stem cells tested in 
this study showed that when supported with BM 
the dental pulp stem cells reach higher ALP values 
at 7, 14 and also 21 days compared to periodontal 
ligament stem cells and follicle stem cells. When 
samples were treated with osteogenic medium 
the dental pulp stem cells once again showed 
the highest ALP values at 21 days and they were 
consistently higher than with maintenance medium. 
The similarities in between bone and dentin is one 
possible reason that explains the higher ALP values 
of dental pulp stem cells compared to the other cell 
lines. 
Recent studies have reported regeneration of 
human bone in vivo using dental pulp stem cells 
combined with collagen biocomplexes supporting 
the concept that hDSCs could be used as a potential 
source of cells for bone regeneration or to test 
future hard tissue regeneration biomaterials [29]. 
The current in vitro study also supports this concept 
[30]. 
In vivo animal studies confirm that stem cells 
combined with an osteoconductive biomaterial are 
committed to regenerate the same tissue from where 
they have been harvested [30,31]. Human studies 
show that a multi-potent population of dental pulp 
stem cells is able to form bone in vivo if implanted 
in a bone defect without any other osteoinductive 
biomaterial except for a collagen sponge [29,32]. It 
could be deduced from these observations that if in 
vitro the induction is fundamental, then  the in vivo 
environment into which the cells are implanted will 
also be a factor, together with the biomaterial used. 
Probably the induction is an aspect coordinated by 
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the host environment. There is growing evidence 
that dental pulp stem cells in the paradigm of 
bone tissue engineering may be a successful 
approach and that DSCs may be advantageous over 
BMSCs.
The growth potential shown by DPSCs, and the fact 
that DSCs are neural crest derived, as is craniofacial 
bone, supports the possibility that biologically 
DPSCs could be used to regenerate bone or other 
calcified tissues in the cranio-maxillofacial area. [33-
35]. Moreover the low morbidity of the otherwise 
necessary extraction of a tooth compared to the 
harvesting of bone marrow or adipose tissue aspirates 
supports the evaluation the role of hDSCs in bone 
regeneration.
Despite the fact that only three patients were 
enrolled in this study, their cells were continuously 
kept separated and not pooled together with 
the different patients. This strengthens the case 
for harvesting dental pulp and other dental 
stem cells from a single patient to study bone 
regeneration.
CONCLUSIONS
The use of dental stem cells for bone regeneration 
could be one future approach to treat bone defects 
of the cranio-maxillofacial skeleton. In vitro tests 
are fundamental first steps before translating this 
technology from the laboratory to clinical application.
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